T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$2.03B |
| 2 |
DuPont de Nemours
DD
|
+$1.83B |
| 3 |
Crown Castle
CCI
|
+$1.58B |
| 4 |
Microsoft
MSFT
|
+$1.48B |
| 5 |
TransUnion
TRU
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.72B |
| 2 |
Starbucks
SBUX
|
+$1.59B |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.3B |
| 4 |
Lowe's Companies
LOW
|
+$1.13B |
| 5 |
Philip Morris
PM
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.97% |
| 2 | Financials | 16.84% |
| 3 | Technology | 15.92% |
| 4 | Consumer Discretionary | 13.45% |
| 5 | Industrials | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Gray Television
GTN
$520M
| $14.3M | ﹤0.01% |
912,691
+65,070
| +8% | +$930K |
|
1277
Range Resources
RRC
$9.39B
| $14.2M | ﹤0.01% |
725,495
-40,679
| -5% | -$786K |
|
1278
IPG Photonics
IPGP
$3.71B
| $14.2M | ﹤0.01% |
76,512
-4,825
| -6% | -$801K |
|
|
BHVN
1279
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $14M | ﹤0.01% |
373,948
-122,180
| -25% | -$3.71M |
|
1280
Children's Place
PLCE
$53.4M
| $14M | ﹤0.01% |
118,229
+12,060
| +11% | +$1.3M |
|
|
KW
1281
DELISTED
Kennedy-Wilson Holdings
KW
| $13.8M | ﹤0.01% |
744,840
+20,740
| +3% | +$400K |
|
1282
Cheesecake Factory
CAKE
$5.57B
| $13.7M | ﹤0.01% |
324,881
+32,401
| +11% | +$1.44M |
|
1283
Middlesex Water
MSEX
$1.1B
| $13.7M | ﹤0.01% |
348,114
+94,130
| +37% | +$3.66M |
|
|
SIOX
1284
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $13.6M | ﹤0.01% |
246,430
-113,557
| -32% | -$19.2M |
|
1285
Onto Innovation
ONTO
$20.6B
| $13.4M | ﹤0.01% |
465,614
+228,323
| +96% | +$6.01M |
|
|
AERI
1286
DELISTED
Aerie Pharmaceuticals
AERI
| $13.3M | ﹤0.01% |
273,373
+41,971
| +18% | +$2.29M |
|
1287
Sportsman's Warehouse
SPWH
$46M
| $13.2M | ﹤0.01% |
2,927,931
+250,260
| +9% | +$1.11M |
|
1288
Advance Auto Parts
AAP
$3.23B
| $13.2M | ﹤0.01% |
132,941
-2,174
| -2% | -$219K |
|
|
TMUSP
1289
DELISTED
T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A
TMUSP
| $13.2M | ﹤0.01% |
132,022
-1,365
| -1% | -$139K |
|
1290
Capri Holdings
CPRI
$1.77B
| $13.1M | ﹤0.01% |
273,355
-3,320
| -1% | -$135K |
|
|
LUMO
1291
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $13.1M | ﹤0.01% |
142,736
+76,847
| +117% | +$5.89M |
|
1292
Standex International
SXI
$4B
| $13M | ﹤0.01% |
122,605
+2,557
| +2% | +$244K |
|
1293
CorVel
CRVL
$3.25B
| $13M | ﹤0.01% |
716,367
+21,732
| +3% | +$363K |
|
|
AIV
1294
Aimco
AIV
$379M
| $13M | ﹤0.01% |
2,221,811
-14,781
| -0.7% | -$88.2K |
|
1295
Ethan Allen Interiors
ETD
$575M
| $13M | ﹤0.01% |
399,710
-323,440
| -45% | -$9.91M |
|
1296
ManpowerGroup
MAN
$2.61B
| $12.9M | ﹤0.01% |
109,541
-3,983
| -4% | -$446K |
|
|
TVTY
1297
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $12.7M | ﹤0.01% |
+311,903
| New | +$12.1M |
|
1298
iShares Russell 2000 ETF
IWM
$82.4B
| $12.7M | ﹤0.01% |
85,734
-13,700
| -14% | -$1.93M |
|
1299
Minerva Neurosciences
NERV
$187M
| $12.7M | ﹤0.01% |
208,339
-29,918
| -13% | -$1.72M |
|
|
OXFD
1300
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $12.6M | ﹤0.01% |
748,627
-25,400
| -3% | -$413K |
|
Similar funds
T. Rowe Price Associates's Q3 2017 Portfolio in Review
As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
- T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
- T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
- T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.
Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.